Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03648450 · ClinicalTrials.gov registry record
Feasibility and Acceptability of the Propeller Monitoring System in Children With Persistent Asthma
A clinical trial, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT03648450: Completed study, sponsored by Connecticut Children's Medical Center.
NCT03648450 is a clinical trial that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03648450 has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The main hypothesis of this study is to see if children and adolescents with poorly controlled asthma will find the Propeller electronic monitoring device is feasible and acceptable, and will result in improved medication adherence and asthma control. Preliminary studies indicate that Propeller can improve medication adherence rates in children with asthma and reduce the number of days of reliever medication used. It also has been shown to reduce missed days of school and hospitalizations due to asthma exacerbations. The Propeller device is a sensor that fits over inhalers and uses Bluetooth connection to cell phones to remind patients to take their medication. It also records use of the controller and rescue inhalers, allowing for parents, physicians, and patients to get a fuller and more accurate picture of their adherence to treatment and severity of disease. With improved adherence, asthma control should improve, resulting in a decreased costs and use of services.
Primary Outcome
This will be assessed by recording the number and percentage of the children and adolescents still using Propeller at three months.
Interventions
- OTHER Propeller EMD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2023-08-31 |
What the finished NCT03648450 record still lists
NCT03648450 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Propeller EMD is the first listed.
NCT03648450 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03648450 about?
NCT03648450 is a clinical study titled "Feasibility and Acceptability of the Propeller Monitoring System in Children With Persistent Asthma". The main hypothesis of this study is to see if children and adolescents with poorly controlled asthma will find the Propeller electronic monitoring device is feasible and acceptable, and will result in improved medication adherence and asthma control. Preliminary studies indicate that Propeller can ...
What is the current status of trial NCT03648450?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2020-11-01. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT03648450?
The interventions under investigation include: Propeller EMD (OTHER).
Who is sponsoring clinical trial NCT03648450?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI